Profil
Vincent J.
Miles currently works at Abingworth Management, Inc., as Executive Director from 2022, IFM Therapeutics LLC, as Director, and Abingworth Management Ltd., as Partner.
Dr. Miles also formerly worked at PrimeraDx, Inc., as Interim President & Chief Executive Officer in 2010, Chiasma, Inc., as Independent Director from 2012 to 2015, Dicerna Pharmaceuticals, Inc., as Independent Director in 2014, Personalis, Inc., as Director, Dana-Farber Cancer Institute, Inc., as Director-Technology Transfer Office, Magellan Diagnostics, Inc., as Director, Hydra Biosciences, Inc., as Director, Novartis Inflammasome Research, Inc., as Director, Millennium Pharmaceuticals, Inc., as VP-Business Development & Technology Management, RiboGene, Inc., as Vice President-Research & Development, Alnylam Pharmaceuticals, Inc., as Senior Vice President-Business Development, Pharmacia Biotech (Biochrom) Ltd., as Vice President-International Marketing, and GE Healthcare Ltd. (United Kingdom), as Research & Development Scientist.
Dr. Miles received his undergraduate degree and doctorate degree from University College London.
Postes actifs de Vincent J. Miles
| Sociétés | Poste | Début |
|---|---|---|
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Corporate Officer/Principal | - |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Directeur/Membre du Conseil | - |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/03/2007 |
Anciens postes connus de Vincent J. Miles
| Sociétés | Poste | Fin |
|---|---|---|
| PERSONALIS, INC. | Directeur/Membre du Conseil | 01/05/2019 |
| CHIASMA, INC. | Directeur/Membre du Conseil | 21/07/2015 |
| DICERNA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/09/2014 |
Novartis Inflammasome Research, Inc.
Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Manufactures molecule drugs | Directeur/Membre du Conseil | - |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Corporate Officer/Principal | - |
Formation de Vincent J. Miles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
RiboGene, Inc.
RiboGene, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
Personalis, Inc.
Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Pharmacia Biotech (Biochrom) Ltd.
Pharmacia Biotech (Biochrom) Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops manufacturs and markets scientific instruments and associated | Electronic Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Magellan Diagnostics, Inc.
Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Health Technology |
Novartis Inflammasome Research, Inc.
Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Manufactures molecule drugs | Health Technology |
















